From the Editor

ASCO 2018: Less is more as ‘tailoring’ takes on new meaning

Author:

Howard A Burris I I I, MD

• Read More

Community Translations

First CAR T-cell therapy approvals bolster booming immunotherapy market

Author:

Edited by Jame Abraham; report by Jane de Lartigue

• Read More

Original Report

Psychosocial factors and treatment satisfaction after radical prostatectomy

Author:

Kundu et al

• Read More

Original Report

The impact of inpatient rehabilitation on outcomes for patients with cancer

Author:

Forrest et al

• Read More

Original Report

The long-term effects of posttreatment exercise on pain in young women with breast cancer

Author:

Ibrahim et al

• Read More

Case Reports

Carcinoma of the colon in a child

Author:

Ahmad et al

• Read More

Case Reports

Effective management of severe radiation dermatitis after head and neck radiotherapy

Author:

Kumar et al

• Read More

Case Reports

Striking rash in a patient with lung cancer on a checkpoint inhibitor

Author:

Tanios et al

• Read More

Case Reports

Recurrence of a small gastric gastrointestinal stromal tumor with high mitotic index

Author:

Skubitz et al

• Read More

New Therapies

Tumor heterogeneity: a central foe in the war on cancer

Author:

Jane De Lartigue, PhD

• Read More

Feature

Therapy updates and clinical challenges

• Read More

Feature

CAR T-cell approvals: multiple myeloma likely next up

Author:

Sharon Worcester

• Read More

Article

Unravelling the CAR T-cell therapy reimbursement riddle

Author:

Alicia Gallegos

• Read More